About BIOE Labs

BioAge is a clinical-stage biotechnology company that develops drugs to treat aging and aging-related diseases. We've built a systems biology platform to map out the key molecular pathways that impact healthy human aging, based on proprietary human aging cohorts that have blood samples collected up to 45 years ago with participant -omics data that is tied to detailed medical follow-up records over their lifespan. To date, BioAge has raised $127M from Andreessen Horowitz, Kaiser Foundation Hospitals, and others. Recently, BioAge in-licensed our first two platform assets, and for both programs we'll be initiating Phase 2 efficacy trials by H1 2021. Our mission is to develop a pipeline of therapeutic assets that increase healthspan and lifespan.

Facts about BIOE Labs
  • Founding: 2015
  • Focus : Manufacturer
  • Industry : Pharma

Here you will find BIOAGE Labs